$95.00 - Webinar Archive 01/07/16 - NM
$45.00 - Webinar Archive 01/07/16 - Member
Original air date: January 7, 2016Run time: 90 minutes
Functional claiming might provide broad claim coverage in the chemical and biotech arts and help overcome 101 ineligibility rejections, but functional claims are inherently vulnerable to invalidity challenges for lack of written description support. In this webinar we will evaluate recent case law on written description and whether functional claiming is worth the risk for various chemical and biotech patent claims. Speakers: Kenneth Jenkins of Mintz Levin, LLP; Suzannah Sundby, Chair, Biotechnology Committee, of Canady + Lortz, LLP; Robert Titus of Eli Lilly and Company; moderated by Carla Mouta of Finnegan Henderson Farabow Garrett & Dunner, LLP.